Quick Comparison
| B-Complex | Emoxypine (Mexidol) | |
|---|---|---|
| Half-Life | Water-soluble; excreted daily (except B12 which is stored) | 2-2.6 hours |
| Typical Dosage | Standard: A quality B-complex providing 25-100 mg of B1, B2, B3, B5, B6, plus 400-800 mcg folate (as methylfolate) and 500-1000 mcg B12 (as methylcobalamin). Methylated forms preferred for B9 and B12 (folate → methylfolate, B12 → methylcobalamin). Take in the morning — B vitamins can be mildly energizing. | Standard: 125-375 mg daily in 2-3 divided doses. Commonly 125 mg twice daily. Take with food. Effects are noticeable within 30-60 minutes. Russian clinical practice uses 4-6 week courses. |
| Administration | Oral (capsules, tablets, sublingual). Methylated forms preferred for B9 and B12. Take with breakfast. | Oral (tablets). Also available as IV/IM injection in clinical settings. Mexidol is the brand name. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
B-Complex
Each B vitamin serves specific neurological functions: B1 (thiamine) — cofactor for transketolase (pentose phosphate pathway), pyruvate dehydrogenase, and alpha-ketoglutarate dehydrogenase; essential for glucose metabolism and ATP production in neurons. B2 (riboflavin) — precursor to FAD/FMN, cofactors for Complex I and II of the electron transport chain, and glutathione reductase. B3 (niacin/niacinamide) — precursor to NAD+/NADPH via the salvage pathway; NAD+ is substrate for sirtuins, PARP, and 400+ dehydrogenases. B5 (pantothenic acid) — component of coenzyme A, required for acetylcholine synthesis via choline acetyltransferase and for fatty acid oxidation. B6 (pyridoxine) — cofactor for AADC (5-HTP to serotonin, L-DOPA to dopamine), GABA synthesis (GAD), and homocysteine metabolism. B9 (folate) — tetrahydrofolate donates methyl groups for dTMP and purine synthesis, and for homocysteine remethylation. B12 (cobalamin) — cofactor for methionine synthase (myelin maintenance) and methylmalonyl-CoA mutase.
Emoxypine (Mexidol)
Emoxypine (2-ethyl-6-methyl-3-hydroxypyridine succinate) has a 3-hydroxypyridine structure similar to vitamin B6 (pyridoxine). It is one of the most potent inhibitors of lipid peroxidation in brain tissue — it scavenges hydroxyl radicals and peroxyl radicals, inhibits Fe2+-induced lipid peroxidation, and may chelate transition metals. It modulates the GABA-benzodiazepine receptor complex (GABA-A), enhancing GABAergic transmission through positive allosteric modulation — possibly at a site distinct from the classical benzodiazepine binding site, explaining the lack of sedation and tolerance. It improves mitochondrial function (Complex I protection, membrane stabilization), stabilizes cell membranes (reducing fluidity changes during oxidative stress), and enhances cerebral microcirculation (possibly via nitric oxide or prostaglandin modulation). The anxiolytic mechanism may involve partial agonism or different subunit selectivity.
Risks & Safety
B-Complex
Common
Bright yellow urine (harmless — riboflavin excretion), mild nausea.
Serious
Very safe at standard doses. B6 can cause peripheral neuropathy at >200 mg daily for extended periods.
Rare
Flushing from niacin (B3) if non-flush form is not used.
Emoxypine (Mexidol)
Common
Mild nausea, drowsiness, dry mouth.
Serious
Limited Western safety data. Allergic reactions reported.
Rare
Elevated blood pressure, emotional lability.
Full Profiles
B-Complex →
The B vitamins (B1, B2, B3, B5, B6, B9, B12) are essential coenzymes in brain energy metabolism, neurotransmitter synthesis, and methylation reactions. Deficiency in any B vitamin impairs cognitive function. B12 and folate deficiency specifically cause irreversible neurological damage if untreated. A high-quality B-complex is foundational for any nootropic regimen, particularly for vegetarians, older adults, and those under chronic stress.
Emoxypine (Mexidol) →
A vitamin B6 derivative with powerful antioxidant and anxiolytic properties, widely prescribed in Russia and Eastern Europe for anxiety, cognitive impairment, and cerebrovascular disease. Emoxypine inhibits lipid peroxidation, modulates GABA-A and benzodiazepine binding sites, and improves cerebral blood flow. It provides anxiolytic effects similar to benzodiazepines without sedation, tolerance, or addiction.